Stuart L. Nightingale, M.D.
Stuart L. Nightingale, M.D. is an independent consultant on public health, science, and regulatory affairs. He has served as a consultant/contractor in the Office of Biotechnology Activities in the NIH Office of Science Policy in the Office of the Director since retiring from the Federal government in 2007. His Federal service included senior management positions in the Office of the Secretary of the Department of Health and Human Services, the Food and Drug Administration, and the Executive Office of the President. At the time he retired Dr. Nightingale was the Deputy Assistant Secretary for Preparedness and Response and Senior Medical Advisor to the Director, Office of Global Health Affairs). At FDA he was Associate Commissioner for Health Affairs and earlier Assistant to the Director, Bureau of Drugs (now CDER). Dr. Nightingale has served on a number of Editorial Boards and was the editor of the “From the FDA” monthly column in the Journal of the American Medical Association. His publications have focused on the treatment use of investigational drugs and biologics, the use of FDA-approved products “off label,” prescription drug information for patients, Direct-to-Consumer advertising of FDA- approved products, and cancer quackery. He received the Presidential Meritorious Executive Rank Award on two occasions and the Surgeon General Exemplary Award. He is a Fellow of the American College of Physicians, the Medical Administrators Conference, and the Senior Executives Association. He is a manuscript reviewer for several medical, scientific, and public health journals.
Dr. Nightingale graduated from Yale University and the New York University School of Medicine. His training in Internal Medicine was at Montefiore Hospital and Medical Center in New York. He served on the faculties of the State University of New York (Downstate) Medical Center and the Johns Hopkins University School of Medicine and the Johns Hopkins University School of Hygiene